STOCK TITAN

Camp4 Therapeutics Corp. Stock Price, News & Analysis

CAMP Nasdaq

Welcome to our dedicated page for Camp4 Therapeutics news (Ticker: CAMP), a resource for investors and traders seeking the latest updates and insights on Camp4 Therapeutics stock.

CAMP4 Therapeutics Corporation (Nasdaq: CAMP) is a clinical-stage biopharmaceutical company developing regulatory RNA-targeting therapeutics designed to upregulate gene expression and restore healthy protein levels in genetic diseases. The CAMP news feed highlights how the company advances its antisense oligonucleotide (ASO) pipeline, progresses clinical and preclinical programs, and enters strategic collaborations.

Readers can follow CAMP4’s updates on its SYNGAP1-related disorders program, including announcements about GLP toxicology studies for CMP-SYNGAP-01, translational data in humanized mouse models and non-human primates, and plans for Phase 1/2 clinical trial applications. News items also cover the company’s Urea Cycle Disorders program and the CMP-CPS-001 (CMP-001) Phase 1 trial, where CAMP4 has reported safety and pharmacokinetics data from single and multiple ascending dose cohorts in healthy volunteers.

CAMP4’s news flow includes financial and corporate updates such as private placements, underwritten offerings of common stock, and use of proceeds to support development of its product candidates. The company also reports on strategic agreements, including a research, collaboration and license agreement with GSK to discover and develop ASO drug candidates for neurodegenerative and kidney disease indications using CAMP4’s RAP Platform.

In addition, CAMP4 issues press releases on scientific presentations at major meetings, corporate highlights, and inducement grants under Nasdaq Listing Rule 5635(c)(4). Investors and observers can use this news page to review CAMP4’s reported milestones, research progress, and financing activities related to its regulatory RNA-targeting therapeutic strategy.

Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced the launch of a telematics service through its subsidiary LoJack Italia and PluService. This innovative service aims to enhance the management and maintenance of transport vehicles, allowing real-time monitoring of vehicle health to prevent mechanical failures. By optimizing maintenance, the collaboration intends to reduce costs and improve operational efficiency for fleet operators. The LoJack Connect technology alerts transport companies about vehicle malfunctions, facilitating swift diagnostics and repairs, which enhances safety and reduces downtime.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.59%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) has partnered with Coastr, a digital car rental innovator, to transform the car rental industry. This collaboration will integrate advanced telematics and AI technology to create flexible, contactless rental experiences. Coastr aims to improve fleet management and customer interaction using CalAmp's Telematics Cloud. The partnership is supported by two significant grants aimed at advancing innovation in the sector. This initiative could enhance market share for car rental companies and streamline operations, benefiting both operators and consumers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
partnership
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) will release its fiscal 2021 third quarter results on December 17, 2020, before the market opens. A conference call to discuss these results will occur at 5:30 a.m. PT (8:30 a.m. ET) on the same day. Investors can access the call via webcast on CalAmp's website or by phone using Conference ID# 4587228. An audio replay will be available until December 24, 2020.

CalAmp is a technology solutions leader in the mobile connected economy, with over 20 million products installed globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
conferences earnings
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced the adoption of its school bus technology by the Iredell-Statesville School District in North Carolina, enhancing safety amidst COVID-19. The district will implement the Bus Guardian system for contact tracing, hygiene verification, and wellness checks, covering 244 buses transporting 11,000 students across 500 routes. Additionally, the popular tracking app 'Here Comes The Bus' will be utilized, promoting safer transportation experiences. This initiative highlights CalAmp's commitment to improving school transportation efficiency and safety amid pandemic challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced a partnership between its subsidiary Tracker and Grove & Dean, a leading UK insurance broker. This collaboration aims to implement initiatives that will safeguard assets, lower insurance premiums, and protect loss ratios. The partnership launches with Tracker's stolen vehicle recovery solutions, which boast a 95% recovery rate, addressing the rising vehicle thefts in the UK. This innovative solution not only enhances vehicle security but also significantly reduces the costs associated with theft for insurers and vehicle owners.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
partnership
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced that Bell Mitsubishi selected LoJack Connect subscription services to enhance customer experience and profitability. This upgrade improves operational efficiency and allows Bell Mitsubishi to offer proactive maintenance services, increasing service revenue. LoJack Connect includes a suite of features for vehicle diagnostics and management, contributing to customer safety and security. Overall, this partnership aims to foster customer loyalty and generate higher profitability for the dealership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
none
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced that its President and CEO, Jeff Gardner, along with CFO Kurt Binder, will participate in the Craig-Hallum Alpha Select Conference on November 17, 2020. This virtual event allows portfolio managers and analysts to engage with CalAmp's management team. With over 20 million products installed and 1.3 million software and services subscribers globally, CalAmp is a leader in mobile IoT solutions, focusing on transforming the mobile connected economy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
conferences
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced the launch of two innovative telematics solutions, iOn Tag and iOn Vision, through its subsidiary LoJack Italia, aimed at enhancing safety and efficiency in commercial fleet operations across Europe. These products utilize AI and data analytics to provide continuous shipment visibility and improve driver safety. iOn Tag tracks assets in real-time and mitigates theft, while iOn Vision offers video insights for better fleet management. LoJack Italia aims to redefine telematics solutions, supporting over 300,000 subscribers in Italy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.66%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced a contract renewal with East Baton Rouge Parish, Louisiana, for fleet management technology aimed at controlling disease-bearing pests. Over 70 municipal vehicles will benefit from CalAmp's GPS solutions, optimizing driver and vehicle monitoring in real-time. The technology aims to enhance safety and reduce healthcare costs linked to diseases like the West Nile Virus, which has caused over 30,000 infections since 2001. CalAmp's commitment to customer service has led to sustained multi-year contracts in public sector fleet management across North America.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.8%
Tags
none
Rhea-AI Summary

CalAmp (CAMP) reported its second quarter fiscal 2021 results, revealing consolidated revenue of $83.5 million, a 4.1% sequential increase but a 10.4% decrease year-over-year. The decline was driven by lower Telematics Systems revenue, impacted by COVID-19. Software & Subscription Services revenue rose 20.2% sequentially to $33.7 million, accounting for 40.3% of total revenue. Net loss was $9.5 million, or $0.28 per share. The company maintains a cautious outlook due to ongoing pandemic effects, with no quarterly guidance provided.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.1%
Tags

FAQ

What is the current stock price of Camp4 Therapeutics (CAMP)?

The current stock price of Camp4 Therapeutics (CAMP) is $5.6 as of March 11, 2026.

What is the market cap of Camp4 Therapeutics (CAMP)?

The market cap of Camp4 Therapeutics (CAMP) is approximately 313.9M.

CAMP Rankings

CAMP Stock Data

313.88M
42.94M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE

CAMP RSS Feed